Urological Science
Volume 21, Issue 4 , Pages 157-162, December 2010

Current Management of Male Chronic Pelvic Pain Syndromes

  • Yung-Shun Juan

      Affiliations

    • Department of Urology, Faculty of Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • ,
  • Jung-Tsung Shen

      Affiliations

    • Department of Urology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan
    • ,
  • Mei-Yu Jang

      Affiliations

    • Department of Urology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan
    • ,
  • Chun-Hsiung Huang

      Affiliations

    • Department of Urology, Faculty of Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • ,
  • Ching-Chia Li

      Affiliations

    • Department of Urology, Faculty of Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • ,
  • Wen-Jeng Wu

      Affiliations

    • Department of Urology, Faculty of Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Urology, Kaohsiung Medical University, 100, Shih-Chuan 1st Road, Kaohsiung 807, Taiwan

Accepted 20 October 2009.

Article Outline

The term prostatitis denotes a combination of infectious conditions (acute and chronic bacterial prostatitis), chronic pelvic pain syndrome (CPPS) and asymptomatic inflammation, of which most of them are CPPS. In spite of many years of investigation, the cause of CPPS remains elusive and can be multifactorial. Different factors have been proposed in the etiopathogenesis of CPPS, including viral infection, psychological stress effects, hormonal and neural factor, T-cell recognition of prostatic peptides, and possibly autoimmune diseases. However, a universally effective, reliable and lasting beneficial treatment of the CP/CPPS remains uncertain. A wide variety of treatments have been applied to CPPS patients, including alpha-blockers, antimicrobial therapy, nonsteroidal anti-inflammatory medicine, heat therapy and local infiltration therapies. Treatment is clinically based on optimal symptomatic relief and pain control. Psychological factors can also affect the development of chronic pain and treatment outcomes. Psychological distress comes from both persistent pelvic pain and worrying about tissue damage or malignancy development. It is important to inform patients about the variety of potential therapies and to develop a trusting relationship with them. Additional studies in the understanding of the etiologies of CP/CPPS and the establishment of treatment strategies are urgently needed.

Key Words:  chronic pelvic pain , management , prostatitis

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Bartoletti R , Cai T , Mondaini N , et al.   Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study . J Urol . 2007;178:2411–2415
  2. Roberts RO , Lieber MM , Rhodes T , Girman CJ , Bostwick DG , Jacobsen SJ . Prevalence of a physician-assigned diagnosis of pros-tatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men . Urology . 1998;51:578–584
  3. Tan JK , Png DJ , Liew LC , Li MK , Wong ML . Prevalence of prostatitis-like symptoms in Singapore: a population-based study . Singapore Med J . 2002;43:189–193
  4. Weidner W , Schiefer HG , Krauss H , Jantos C , Friedrich HJ , Altmannsberger M . Chronic prostatitis: a thorough search for etio-logically involved microorganisms in 1,461 patients . Infection . 1991;19(Suppl 3):S119–S125
  5. Meares EM , Stamey TA . Bacteriologic localization patterns in bacterial prostatitis and urethritis . Invest Urol . 1968;5:492–518
  6. Nickel JC . The Pre and Post Massage Test (PPMT): a simple screen for prostatitis . Tech Urol . 1997;3:38–43
  7. Litwin MS , McNaughton-Collins M , Fowler FJ , et al.   The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network . J Urol . 1999;162:369–375
  8. Doble A , Harris JR , Taylor-Robinson D . Prostatodynia and herpes simplex virus infection . Urology . 1991;38:247–248
  9. Mazzoli S , Cai T , Rupealta V , et al.   Interleukin 8 and anti-Chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection . Eur Urol . 2007;51:1385–1393
  10. Mehik A , Hellstrom P , Sarpola A , Lukkarinen O , Jarvelin MR . Fears, sexual disturbances and personality features in men with prosta-titis: a population-based cross-sectional study in Finland . BJU Int . 2001;88:35–38
  11. Diserio GP , Carrizo AE , Pacheco-Rupil B , Nowotny E . Effect of male accessory glands autoaggression on androgenic cytosolic and nuclear receptors of rat prostate . Cell Mol Biol . 1992;38:201–207
  12. Nickel JC , Downey J , Pontari MA , Shoskes DA , Zeitlin SI . A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis) . BJU Int . 2004;93:991–995
  13. Motrich RD , Maccioni M , Molina R , et al.   Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients . Clin Immunol . 2005;116:149–157
  14. Tomaskovic I , Ruzic B , Trnski D , Kraus O . Chronic prostatitis/chronic pelvic pain syndrome in males may be an autoimmune disease, potentially responsive to corticosteroid therapy . Med Hypotheses . 2009;72:261–262
  15. Rudick CN , Schaeffer AJ , Thumbikat P . Experimental autoimmune prostatitis induces chronic pelvic pain . Am J Physiol Regul Integr Comp Physiol . 2008;294:R1268–R1275
  16. Penna G , Amuchastegui S , Cossetti C , et al.   Spontaneous and pros-tatic steroid binding protein peptide-induced autoimmune prosta-titis in the nonobese diabetic mouse . J Immunol . 2007;179:1559–1567
  17. Jang TL , Schaeffer AJ . The role of cytokines in prostatitis . World J Urol . 2003;21:95–99
  18. Barbalias GA , Nikiforidis G , Liatsikos EN . Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics . J Urol . 1998;159:883–887
  19. Mehik A , Hellstrom P , Lukkarinen O , Sarpola A , Alfthan O . Prostatic tissue pressure measurement as a possible diagnostic procedure in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome . Urol Res . 2000;28:316–318
  20. Mehik A , Alas P , Nickel JC , Sarpola A , Helstrom PJ . Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study . Urology . 2003;62:425–429
  21. Cheah PY , Liong ML , Yuen KH , et al.   Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial . J Urol . 2003;169:592–596
  22. Nickel JC , Narayan P , McKay J , Doyle C . Treatment of chronic pros-tatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial . J Urol . 2004;171:1594–1597
  23. Nickel JC , Krieger JN , McNaughton-Collins M , et al.   Alfuzosin and symptoms of chronic prostatitis/chronic pelvic pain syndrome . N Engl J Med . 2008;359:2663–2673
  24. Nickel JC , Downey J , Clark J , et al.   Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial . Urology . 2003;62:614–617
  25. Alexander RB , Propert KJ , Schaeffer AJ , et al.   Ciprofloxacin or tam-sulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial . Ann Intern Med . 2004;141:581–589
  26. Kajander EO , Ciftcioglu N , Miller-Hjelle MA , Hjelle JT . Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease . Curr Opin Nephrol Hypertens . 2001;10:445–452
  27. Miller VM , Rodgers G , Charlesworth JA , et al.   Evidence of nano-bacterial-like structures in calcified human arteries and cardiac valves . Am J Physiol Heart Circ Physiol . 2004;287:H1115–H1124
  28. Shoskes DA , Thomas KD , Gomez E . Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience . J Urol . 2005;173:474–477
  29. Zhou Z , Hong L , Shen X , et al.   Detection of nanobacteria infection in type III prostatitis . Urology . 2008;71:1091–1095
  30. Nickel JC . Treatment of chronic prostatitis/chronic pelvic pain syndrome . Int J Antimicrob Agents . 2008;31(Suppl 1):S112–S116
  31. Nickel JC , Pontari M , Moon T , et al.   A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis . J Urol . 2003;169:1401–1405
  32. Kastner C , Hochreiter W , Huidobro C , Cabezas J , Miller P . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis-results of a pilot study after 1 year . Urology . 2004;64:1149–1154
  33. Zeitlin SI . Heat therapy in the treatment of prostatitis . Urology . 2002;60:38–41
  34. Chiang PH , Chiang CP . Therapeutic effect of transurethral needle ablation in non-bacterial prostatitis: chronic pelvic pain syndrome type IIIa . Int J Urol . 2004;11:97–102
  35. Leskinen MJ , Kilponen A , Lukkarinen O , Tammela TL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham-controlled study . Urology . 2002;60:300–304
  36. Shoskes DA , Berger R , Elmi A , Landis JR , Propert KJ , Zeitlin S . Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study . J Urol . 2008;179:556–560
  37. Chuang YC , Chiang PH , Huang CC , Yoshimura N , Chancellor MB . Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates . Urology . 2005;66:775–779
  38. Chuang YC , Chiang PH , Yoshimura N , De Miguel F , Chancellor MB . Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia . BJU Int . 2006;98:1033–1037
  39. Chuang YC , Chancellor MB . The application of botulinum toxin in the prostate . J Urol . 2006;176:2375–2382
  40. Zermann D , Ishigooka M , Schubert J , Schmidt RA . Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? . Eur Urol . 2000;38:393–399
  41. Chuang YC , Yoshimura N , Huang CC , Wu M , Chiang PH , Chancellor MB . Intraprostatic botulinum toxin a injection inhibits cyclooxy-genase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat . J Urol . 2008;180:742–748
  42. Naslund MJ , Strandberg JD , Coffey DS . The role of androgens and estrogens in the pathogenesis of experimental nonbacterial pros-tatitis . J Urol . 1988;140:1049–1053
  43. Leskinen M , Lukkarinen O , Marttila T . Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a doubleblind, placebo-controlled, pilot study . Urology . 1999;53:502–505
  44. Alp BF , Akyol I , Adayener C , et al.   The significance of potassium chloride sensitivity test and urinary uronic acid level in the diagnosis of chronic pelvic pain syndrome . Int Urol Nephrol . 2009;41:483–489
  45. Nickel JC , Forrest JB , Tomera K , et al.   Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study . J Urol . 2005;173:1252–1255
  46. Nickel JC , Johnston B , Downey J , et al.   Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial . Urology . 2000;56:413–417
  47. Wagenlehner FM , Schneider H , Ludwig M , Schnitker J , Brahler E , Weidner W . A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study . Eur Urol . 2009;56:544–551
  48. Zimmermann R , Cumpanas A , Hoeltl L , Janetschek G , Stenzl A , Miclea F . Extracorporeal shock-wave therapy for treating chronic pelvic pain syndrome: a feasibility study and the first clinical results . BJU Int . 2008;102:976–980
  49. Schaeffer AJ . Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome . N Engl J Med . 2006;355:1690–1698
  50. Wagenlehner FM , Naber KG , Bschleipfer T , Brahler E , Weidner W . Prostatitis and male pelvic pain syndrome: diagnosis and treatment . Dtsch Arztebl Int . 2009;106:175–183
  51. Mayer RD , Howard FM . Sacral nerve stimulation: neuromodulation for voiding dysfunction and pain . Neurotherapeutics . 2008;5:107–113

 There are 4 CME questions based on this article

PII: S1879-5226(10)60036-X

doi:10.1016/S1879-5226(10)60036-X

Urological Science
Volume 21, Issue 4 , Pages 157-162, December 2010

Article Tools